Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated prevalence of age-related macular degeneration in a low-income urban primary care setting.

Discover public health·2026
Same author

The Sleeping Wolf - Widefield OCT Angiography Revelations of Insidious Systemic Lupus Erythematous-Associated Retinal Vasculitis.

Retinal cases & brief reports·2026
Same author

Subretinal drusenoid deposits are strongly associated with coexistent high-risk vascular diseases.

BMJ open ophthalmology·2026
Same author

Re: Chen et al.: High-density lipoproteins associated with age-related macular degeneration in the All of Us research program (Ophthalmology. 2025;132:684-691).

Ophthalmology·2025
Same author

Vitreoretinal Involvement in Patients With Fungemia at a Tertiary Care Hospital.

Journal of vitreoretinal diseases·2025
Same author

Cytokines in PD-1 immune checkpoint inhibitor adverse events and implications for the treatment of uveitis.

BMC ophthalmology·2024

Related Experiment Video

Updated: May 11, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

Inflammation in retinal vein occlusion.

Avnish Deobhakta1, Louis K Chang

  • 1Department of Ophthalmology, Columbia University Medical Center, New York, NY 10032, USA.

International Journal of Inflammation
|May 9, 2013
PubMed
Summary

Inflammation plays a key role in retinal vein occlusion (RVO), a common cause of vision loss. Understanding these inflammatory pathways is leading to new treatments for RVO and related macular edema.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Immunology

Background:

  • Retinal vein occlusion (RVO) is a frequent and serious vascular condition impacting vision.
  • Systemic inflammatory conditions, including autoimmune diseases, are established risk factors for RVO.
  • Emerging research highlights inflammation's role in RVO pathogenesis and its vision-threatening complications like macular edema.

Purpose of the Study:

  • To explore the significance of inflammation in the development and progression of retinal vein occlusion.
  • To investigate the molecular mechanisms through which inflammation contributes to vision impairment in RVO.
  • To identify novel therapeutic targets for managing RVO based on inflammatory pathways.

Main Methods:

  • Review of current laboratory and clinical studies on inflammation and RVO.

More Related Videos

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Related Experiment Videos

Last Updated: May 11, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

  • Analysis of molecular pathways implicated in RVO-associated macular edema.
  • Evaluation of existing and potential therapeutic strategies targeting inflammation in RVO.

    • Main Results:

    • Inflammation is increasingly recognized as a central factor in RVO.
    • Specific inflammatory pathways are linked to vision-impairing consequences such as macular edema.
    • Understanding these pathways facilitates the development of targeted treatments.

    Conclusions:

    • Inflammation is a critical component in the pathophysiology of retinal vein occlusion.
    • Targeting inflammatory mechanisms offers promising therapeutic avenues for RVO and associated macular edema.
    • Further research into inflammatory pathways will likely uncover additional treatment strategies for RVO.